
|Articles|April 24, 2020
CDC issues tips for reusing N95 masks
To keep health care providers safe, the Centers for Disease Control and Prevention has issued a collection of tips that guidelines for extending use, recommendations for extended use, reuse recommendations, and a look at the risks that reuse or extended use can carry.
Advertisement
The COVID-19 has stressed the personal protective equipment reserves of many hospitals and practices, leaving many to extend or reuse N95 masks.
To keep health care providers safe, the Centers for Disease Control and Prevention has issued a collection of tips that guidelines for extending use, recommendations for extended use, reuse recommendations, and a look at the risks that reuse or extended use can carry.
Advertisement
Related to this article

A GBD analysis of 204 countries estimated measles cases in children under 5 rose from 11.1 million in 2019 to 15.6 million in 2023.

Completing the DTaP primary series was 96.2% effective against pertussis in Alaska children aged 6 months to 6 years during a record 2024 outbreak.

Hai D. Nguyen-Tran, MD, discusses clinical signs, neurologic warning symptoms, supportive care, and preventing the spread of hand, foot, and mouth disease.

Diana F. Clarke, PharmD, explains how IMPAACT 2023 supported dolutegravir from birth, plus dosing tips and open questions for preterm infants.

An updated AAP policy statement renews the call to ban raw milk sales, citing pathogen risks to children and pregnant people and an emerging H5N1 concern.

At AAP 2026, Rana Hamdy, MD, discussed when to test children for group A strep, antibiotic selection, and strategies to improve prescribing.

Jonathan Miller, MD, discusses earlier HPV vaccination, individualized conversations with hesitant families, and strategies to improve vaccine uptake.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Recognizing skin conditions in children with darker skin tones
2
Global measles cases in children under 5 up 40% since COVID-19
3
FAQ: How should pediatricians manage UTIs under new AAP guidance?
4
Tezepelumab sustains EoE remission through 52 weeks
5
